The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $181.22 million. The enterprise value is $390.66 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 124.12 million shares outstanding. The number of shares has decreased by -6.82% in one year.
| Current Share Class | 124.12M |
| Shares Outstanding | 124.12M |
| Shares Change (YoY) | -6.82% |
| Shares Change (QoQ) | -12.59% |
| Owned by Insiders (%) | 8.18% |
| Owned by Institutions (%) | 59.86% |
| Float | 80.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| Forward PS | 0.55 |
| PB Ratio | 3.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.56, with a Debt / Equity ratio of 9.52.
| Current Ratio | 6.56 |
| Quick Ratio | 5.35 |
| Debt / Equity | 9.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.98 |
Financial Efficiency
Return on equity (ROE) is -37.64% and return on invested capital (ROIC) is -6.72%.
| Return on Equity (ROE) | -37.64% |
| Return on Assets (ROA) | -5.90% |
| Return on Capital (ROIC) | -6.72% |
| Revenue Per Employee | $394,574 |
| Profits Per Employee | -$31,976 |
| Employee Count | 881 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, SKIN has paid $1.54 million in taxes.
| Income Tax | 1.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.80% in the last 52 weeks. The beta is 0.86, so SKIN's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -53.80% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 45.61 |
| Average Volume (20 Days) | 595,677 |
Short Selling Information
The latest short interest is 8.18 million, so 6.59% of the outstanding shares have been sold short.
| Short Interest | 8.18M |
| Short Previous Month | 7.56M |
| Short % of Shares Out | 6.59% |
| Short % of Float | 10.15% |
| Short Ratio (days to cover) | 8.46 |
Income Statement
In the last 12 months, SKIN had revenue of $347.62 million and -$28.17 million in losses. Loss per share was -$0.43.
| Revenue | 347.62M |
| Gross Profit | 175.64M |
| Operating Income | -78.98M |
| Pretax Income | -80.63M |
| Net Income | -28.17M |
| EBITDA | -41.88M |
| EBIT | -78.98M |
| Loss Per Share | -$0.43 |
Full Income StatementBalance Sheet
The company has $358.89 million in cash and $568.33 million in debt, giving a net cash position of -$209.44 million or -$1.69 per share.
| Cash & Cash Equivalents | 358.89M |
| Total Debt | 568.33M |
| Net Cash | -209.44M |
| Net Cash Per Share | -$1.69 |
| Equity (Book Value) | 59.72M |
| Book Value Per Share | 0.48 |
| Working Capital | 411.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.51 million and capital expenditures -$710,000, giving a free cash flow of -$6.22 million.
| Operating Cash Flow | -5.51M |
| Capital Expenditures | -710,000 |
| Free Cash Flow | -6.22M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 50.53%, with operating and profit margins of -22.72% and -8.10%.
| Gross Margin | 50.53% |
| Operating Margin | -22.72% |
| Pretax Margin | -7.66% |
| Profit Margin | -8.10% |
| EBITDA Margin | -12.05% |
| EBIT Margin | -22.72% |
| FCF Margin | n/a |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.82% |
| Shareholder Yield | 6.82% |
| Earnings Yield | -15.55% |
| FCF Yield | -3.43% |
Analyst Forecast
The average price target for SKIN is $2.55, which is 74.66% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.55 |
| Price Target Difference | 74.66% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 3.18% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.18 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.18 |
| Piotroski F-Score | 5 |